WP Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
WP Advisors's PFE Position: Q1 2026 in Review
WP Advisors reduced its Pfizer (PFE) stake by 3.3% in Q1 2026, selling an estimated $459K and leaving 509,121 shares worth $14.3M. The position accounts for 3.7% of the portfolio, ranked #8.
WP Advisors first reported a position in PFE in Q1 2018 and has held it in 27 quarters since. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- WP Advisors held 509,121 shares of Pfizer worth $14.3M as of Q1 2026.
- WP Advisors sold 17,222 Pfizer shares in Q1 2026, an estimated $459K.
- Pfizer made up 3.7% of WP Advisors's portfolio in Q1 2026, its #8 holding.
- WP Advisors first reported a position in Pfizer in Q1 2018 and has held it in 27 quarters since.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on WP Advisors's 13F filing for Q1 2026, filed 4 May 2026.